molConcept GmbHMolecular drug design is a time and cost-intensive procedure, which ties up many resources. That is why a target-oriented development of drugs can only be applied by using computer-technology. Molecular interactions are able to be planed and calculated on the basis of simulations in the forefront of design specifications.
Our company is a spin-off initiated in the research group "Computational Drug Design" from the Zuse Institute Berlin. We are specialized in optimising available processor capacities by using adequate software design based on modern algorithms.
We are breaking through the barrier, which is given by conventional software, and paving the path for efficient drug design. We offer special concepts and approaches for your company. Furthermore we assist your company by any modeling questions - all on site!
Here you’ll find mathematic and computer-based solutions for all questions of drug design.
Our company counts on the world wide leading methods of Computational Drug Design and faces new challenges; the point is the cost-effective simulation of improved drug concepts.
We would be pleased to collaborate with you!
Copyright by molConcept 2008